Basilea Shares Dive After Antibiotic Setback; Reviews Options
Basilea Shares Dive After Antibiotic Setback; Reviews Options
ZURICH -(Dow Jones)- Basilea Pharmaceutica AG (BSLN.EB) saw nearly one-fourth of its market capitalization sliced off after the company said it would have to review its options because of a setback to a key, broad-spectrum antibiotic.
Read more on Nasdaq
1 New DETECT .999 Fine PIated GOLD Half Eagle CIad Bullion Bars Coins Scrap AU K
 | US $9.99 (0 Bid) End Date: Friday Feb-10-2012 20:37:54 PST Bid now | Add to watch list |
